Evidence map›Paper›PMID 28053724›Full record

ArticleSpinal cord series and cases2015

Charcot spinal arthropathy: an increasing long-term sequel after spinal cord injury with no straightforward management.

Lukas Grassner, Martina Geuther, Orpheus Mach, Volker Bühren, Jan Vastmans, Doris Maier

Erratum issuedAbstract read
In one paragraph

Article in Spinal cord series and cases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. A comprehensive review of the treatment and management of Charcot spine.Therapeutic advances in musculoskeletal disease · 2020
    Review
  6. Article
  7. Article
  8. Infected charcot spine arthropathy.Spinal cord series and cases · 2018
    Article
  9. Article
  10. Article
  11. Charcot spinal arthropathy.Journal of craniovertebral junction & spine
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Lukas GrassnerCenter for Spinal Cord Injuries, Trauma Center Murnau, Bavaria, Germany; Institute of Molecular Regenerative Medicine, SCI-TReCS (Spinal Cord Injury and Tissue Regeneration Center Salzburg), Paracelsus Medical University, Salzburg, Austria.
Martina GeutherCenter for Spinal Cord Injuries, Trauma Center Murnau , Bavaria, Germany.
Orpheus MachCenter for Spinal Cord Injuries, Trauma Center Murnau , Bavaria, Germany.
Volker BührenCenter for Spinal Cord Injuries, Trauma Center Murnau , Bavaria, Germany.
Jan VastmansCenter for Spinal Cord Injuries, Trauma Center Murnau , Bavaria, Germany.
Doris MaierCenter for Spinal Cord Injuries, Trauma Center Murnau , Bavaria, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Charcot spinal arthropathy (CSA) is most likely increasing in patients suffering from consequences of spinal cord injury. We want to highlight initial symptoms, certain risk factors and perioperative complications of this condition. A single center retrospective case series in a specialized Center for Spinal Cord Injuries, BG Trauma Center Murnau, Germany highlighting the potential obstacles in the management of Charcot spine. We describe four female paraplegic patients (mean age: 50.75 years; range: 42-67), who developed Charcot spinal arthropathies. The mean age at the time of the accident was 21.5 years (3-35), the time lag after the accident before CSA was developed and finally diagnosed was on average 29.5 years (17-39) and the mean follow-up period was 39.5 months (6-73). Patient histories, initial symptoms, risk factors as well as the management and postoperative complications are provided. Charcot spine is an important potential sequel of spinal cord injury, which can lead to significant disability and spinal emergencies in affected individuals. More studies are needed to provide better recommendations for spine surgeons. Conservative treatment is an option. Posterior fixation alone does not seem to be sufficient.

Indexed as

Central nervous systemSpinal cord diseases

Identifiers

PMID28053724
PMCPMC5129447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.